Kristin Peck
Publishing timestamp: 2024-02-28 07:11:45
Summary
Zoetis CEO Kristin Peck has helped her company receive approval for a monoclonal antibody treatment for osteoarthritis pain in dogs, tapping into a new billion-dollar market. The bond between pets and their owners has strengthened, leading to increased pet spending and ownership levels. Peck's focus on innovation in animal medicine has not only helped pet owners but also her own dog, who is now benefiting from the new treatment.
Sentiment: POSITIVE
Tickers: ZTS,
Keywords: media, business news, zoetis inc, exclude from automated curation,
Source: https://www.cnbc.com/2024/02/28/kristin-peck-cnbc-changemakers.html